The report of male gender and retinopathy status improves the current consensus guidelines for the screening of myocardial ischemia in asymptomatic type 2 diabetic patients

Abstract

Background and aimsAmerican Diabetes Association (ADA), French-speaking Societies for diabetes & cardiology (ALFEDIAM-SFC) and Cardiac Radionuclide Imaging (CRI) have proposed guidelines for the screening of silent myocardial ischemia (SMI). The aim of the study was to evaluate their diagnostic values and how to improve them. Methods and results731 consecutive type 2 diabetic patients with ≥1 additional risk factor were screened between 1992 and 2006 for SMI by stress myocardial scintigraphy and for silent coronary artery disease (CAD) by coronary angiography. A total of 215 (29.4%) patients had SMI, and 79 of them had CAD. ADA (Odds Ratio 1.7 [95% Confidence Interval: 1.2–2.5]; p < 0.05), ALFEDIAM-SFC (OR 1.5 [1.0–2.5], p < 0.05) and CRI criteria (OR 2.0 [1.4–2.8], p < 0.01) predicted SMI. Considering the presence of male gender and retinopathy added to the prediction of SMI allowed by ADA criteria (c statistic: area under the curve AROC 0.651 [0.605–0.697] versus 0.582 [0.534–0.630]), p < 0.01 and ALFEDIAM-SFC criteria (AROC 0.672 [0.620–0.719] versus 0.620 [0.571–0.670], p < 0.05). CRI prediction of SMI was improved by considering the presence of macroproteinuria and retinopathy (AROC 0.621 [0.575–0.667] versus 0.594 [0.548–0.641], p < 0.01). Severe retinopathy (OR 3.4 [1.2–9.4], p < 0.05), smoking habits (OR 2.1 [1.1–4.2], p < 0.05) and triglyceride levels (OR 1.3 [1.0–1.6], p < 0.05) were independent predictors of CAD in the patients with SMI. ConclusionCurrent guidelines criteria are able to predict SMI but prediction may be improved by considering male gender and the presence of retinopathy. CAD is more frequent in the patients with SMI who are current smokers, have severe retinopathy and higher triglyceride levels.